What Is It and How Does It Work?
ABS-201 (originally known as HMI-115) is an “AI-designed antibody” that you receive as an injection. Most hair loss treatments work by blocking hormones like DHT or increasing blood flow, but they only work for as long as you keep taking them.
ABS-201 is different because it targets the prolactin receptor—a specific docking port on your hair follicles that, when overactive, causes hair to stop growing. By using Artificial Intelligence to design a perfect “key” to lock this port, the treatment doesn’t just stop hair loss; it “rebuilds the machinery” inside the scalp. It restores the natural environment (the stem cell niche) that follicles need to stay healthy and productive.
The Science and the Results
Scientists shared “remarkable” long-term findings from human studies during a healthcare conference on April 21, 2026. The data tracked patients who had stopped using the treatment years ago.
The clear results from the study:
-
Permanent Growth: Patients were treated for only 6 months, but they continued to grow new hair 4 years after their last dose.
-
True Follicle Repair: Mechanistic testing showed that the drug successfully repaired the “stem cell machinery” required to reverse the shrinking of hair follicles.
-
AI Precision: Because the medicine was designed by AI, it targets only the specific prolactin receptors on the scalp, avoiding the body-wide side effects common with traditional pills.
“They continue to grow their hair 4 years post-treatment, which shows from a mechanistic standpoint that they were able to rebuild the stem cell niche,” explained the research team at Absci Corporation. Experts noted that this provides a “huge proof point” that AI-designed antibodies can solve chronic conditions like pattern hair loss faster and more effectively than traditional methods.
When Can You Get It?
ABS-201 is currently moving through advanced human testing. The company announced that they are starting a new “Phase 2” study in late 2026 to confirm these long-term results in a larger group of people. If these tests remain successful, it is expected to be available for doctors to prescribe by 2028 or 2029.
How you can benefit from this treatment now
This breakthrough confirms a major new discovery: hair loss is not just a genetic “sentence” but a mechanical failure of the scalp environment that can be fixed. While this specific antibody is finishing its final checks, you can benefit now by focusing on “follicle health” rather than just “hair appearance.” Doctors recommend using current, proven treatments to save your existing hair follicles now; the healthier your follicles are today, the better they will respond to these upcoming “re-building” therapies like ABS-201 once they are released.